Today: 29 April 2026
Browse Category

Stock Market 5 February 2026

Capgemini to sell ICE-linked U.S. unit as shares slip — what’s driving the backlash

Capgemini to sell ICE-linked U.S. unit as shares slip — what’s driving the backlash

Capgemini shares fell to 118.05 euros after the company announced plans to sell its U.S. subsidiary Capgemini Government Solutions, which handles contracts for U.S. Immigration and Customs Enforcement. French officials had pressed Capgemini over the unit’s $14.7 million in ICE-related skip-tracing contracts. Capgemini cited U.S. security restrictions as a barrier to oversight. The sale process will begin immediately.
5 February 2026
··
MercadoLibre stock slips with Wall Street tech selloff as MELI earnings loom

MercadoLibre stock slips with Wall Street tech selloff as MELI earnings loom

MercadoLibre shares fell 1.1% to $2,029.60 Thursday after a tech selloff triggered by Alphabet’s warning of higher AI costs in 2026. The S&P 500 ETF dropped 1.3%, while Amazon and Shopify also declined. MercadoLibre will report fourth-quarter results on Feb. 24. Analysts cited volatility tied to broader growth stock sentiment rather than company-specific news.
5 February 2026
··
SoFi stock price slides 5% as risk-off hits growth names; what traders watch next

SoFi stock price slides 5% as risk-off hits growth names; what traders watch next

SoFi Technologies shares dropped 5.3% to $19.65 Thursday afternoon, extending losses despite a JPMorgan upgrade earlier this week. Investors reacted to SoFi’s 2026 growth targets and a broader selloff in fintech and consumer-lending stocks. Affirm and Upstart also fell sharply. Attention shifts to next week’s delayed U.S. jobs and inflation data for clues on interest rates.
5 February 2026
··
Confluent stock holds near $31 IBM bid as new SEC filing details shareholder suits, Feb. 12 vote

Confluent stock holds near $31 IBM bid as new SEC filing details shareholder suits, Feb. 12 vote

Confluent shares edged up 0.1% to $30.37 Thursday after the company disclosed new details on shareholder litigation tied to its pending $11 billion IBM acquisition. The stock traded about 2% below IBM’s $31-per-share offer as investors watched for the Feb. 12 shareholder vote and Confluent’s earnings report on Feb. 11.
5 February 2026
···
KLA stock rebounds after ASE flags big advanced-packaging push — what KLAC traders watch next

KLA stock rebounds after ASE flags big advanced-packaging push — what KLAC traders watch next

KLA shares rose about 2.3% to $1,337.09 Thursday afternoon after Argus raised its price target to $1,750. ASE Technology projected its advanced packaging segment to double by 2026 and announced $1.5 billion in new machinery investments. An ASE unit bought KLA machinery for T$1.14 billion. Other chip-tool stocks, including Applied Materials and Lam Research, also advanced.
5 February 2026
·
PotlatchDeltic stock price today: Why PCH stopped trading after the Rayonier merger

PotlatchDeltic stock price today: Why PCH stopped trading after the Rayonier merger

PotlatchDeltic shares were suspended and delisted after closing its merger with Rayonier, with the final PCH price at $41.73. Each PCH share converts to 1.8185 Rayonier shares plus $0.61 in cash. Rayonier stock fell about 1% in afternoon trading, lowering the implied payout for former PCH holders. The merged company controls over four million acres of timberland.
5 February 2026
··
Polestar stock surges up to 36% as $400 mln funding close nears — PSNY back in play

Polestar stock surges up to 36% as $400 mln funding close nears — PSNY back in play

Polestar shares jumped as much as 36% to $17.35 Thursday before settling near $16, after closing at $12.74 the previous day. The EV maker is finalizing a $400 million PIPE deal at $19.34 per ADS, set to close by Feb. 5. Analysts tracked by MarketBeat maintain a “Reduce” rating despite the surge. Nasdaq warned Polestar in October to meet minimum bid price requirements by April 2026.
5 February 2026
··
ConocoPhillips stock slides after earnings miss, $1 billion cost-cut plan — what COP investors watch next

ConocoPhillips stock slides after earnings miss, $1 billion cost-cut plan — what COP investors watch next

ConocoPhillips shares fell 2.4% to $105.04 after the company missed fourth-quarter profit estimates and announced a $1 billion cost-cut target for 2026. Adjusted profit was $1.02 per share, below the $1.11 analyst estimate, as oil prices dropped ahead of U.S.-Iran talks. The company reaffirmed plans to return 45% of 2026 operating cash to shareholders.
5 February 2026
···
Ondas stock slides again after J Capital critique; Singapore Airshow headlines keep ONDS in focus

Ondas stock slides again after J Capital critique; Singapore Airshow headlines keep ONDS in focus

Ondas Inc shares fell 10.7% to $8.64 Thursday after J Capital Research questioned its acquisition strategy and raised concerns over shareholder dilution. The drop followed news of a new Asia-Pacific defense contract and a deal to acquire UK-based Rotron Aero. Trading volume reached about 79.2 million shares. Key terms of the new contract and acquisition remain undisclosed.
5 February 2026
·
Alphabet stock slips as Google’s $185 billion AI spend plan rattles traders

Alphabet stock slips as Google’s $185 billion AI spend plan rattles traders

Alphabet shares fell 1% to $329.58 Thursday after the company disclosed a sharp increase in AI infrastructure spending and projected 2026 capital expenditures up to $185 billion. Fourth-quarter revenue rose 18% to $113.83 billion, with Google Cloud revenue jumping 48% to $17.66 billion. The stock earlier touched a low of $306.74 before partially recovering.
5 February 2026
···
PayPal stock slides again as downgrades pile up after CEO shake-up

PayPal stock slides again as downgrades pile up after CEO shake-up

PayPal shares fell 3.3% to $39.67 Thursday after the company named HP’s Enrique Lores as CEO and warned of a weaker 2026 outlook. CFO Jamie Miller cited pressure on retail merchants and sluggish branded checkout growth. Multiple analysts downgraded the stock, citing competition from Apple Pay and Google Pay. PayPal declared a $0.14 dividend and forecast a mid-single-digit drop in Q1 adjusted earnings.
5 February 2026
·
Estée Lauder stock sinks 21% as 2026 outlook, tariffs rattle investors

Estée Lauder stock sinks 21% as 2026 outlook, tariffs rattle investors

Estée Lauder shares fell 21% Thursday to $94.45 after a full-year forecast pointed to slower growth in its main market. The company reported fiscal Q2 net sales of $4.229 billion and raised its 2026 outlook, but warned of higher tariffs and shrinking Q3 margins. Estée Lauder plans to cut up to 7,000 jobs and pay a 35-cent dividend March 16. Coty and e.l.f. Beauty shares also dropped.
5 February 2026
·
Intel stock swings, then steadies as CEO revives GPU push and SoftBank memory deal stays in focus

Intel stock swings, then steadies as CEO revives GPU push and SoftBank memory deal stays in focus

Intel shares rose 0.6% to $48.89 Thursday afternoon after a volatile session, outperforming much of the U.S. tech sector. CEO Lip-Bu Tan announced plans to develop data-center GPUs, directly challenging Nvidia, and SoftBank’s SAIMEMORY signed a memory tech deal with Intel. CFO David Zinsner sold nearly 60,000 shares on Feb. 2. New Xeon 600 workstation chips will be available in late March.
5 February 2026
····
1 … 229 230 231 232 233 … 1,399

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Cambridge, Massachusetts, April 29, 2026, 09:04 EDT Biogen Inc. cut its full-year profit outlook on Wednesday, taking some shine off a first-quarter earnings beat driven by stronger sales of its Alzheimer’s drug Leqembi and newer rare-disease medicines. The Cambridge, Massachusetts-based drugmaker now expects 2026 adjusted earnings of $14.25 to $15.25 a share, down $1 at both ends of its prior range. Biogen said the cut reflects acquired in-process research and development charges, meaning costs tied to buying or licensing drug programs that are still being developed and have not yet become commercial products. (marketscreener.com) The revision matters because Biogen is
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Go toTop